Editorial: Chronic Liver Disease: New Targets and New Mechanisms

被引：1
|
作者：
Ye, Yanting [1 ]
Wang, Hua [2 ]
Gao, Jinhang [1 ]
Kostallari, Enis [3 ]
机构：
[1] Sichuan Univ, West China Hosp, Lab Gastroenterol & Hepatol, State Key Lab Biotherapy, Chengdu, Peoples R China
[2] Anhui Med Univ, Dept Oncol, Affiliated Hosp 1, Hefei, Peoples R China
[3] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
来源：
FRONTIERS IN MOLECULAR BIOSCIENCES | 2022年 / 9卷
关键词：
chronic liver disease; NASH; ALD; cirrhosis; hepatitis; biomarkers; therapeutic targets; PROTEIN;
D O I：
10.3389/fmolb.2022.963630
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Editorial: Platelets in Disease: From Biomarkers Discovery to Therapeutic Targets
    Zhao, Fan
    Zhang, Si
    Zhang, Shenghui
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [42] New metrics for the Lancet Standing Commission on Liver Disease in the UK
    Williams, Roger
    Alexander, Graeme
    Aspinall, Richard
    Bosanquet, Joanne
    Camps-Walsh, Ginette
    Cramp, Matthew
    Day, Natalie
    Dhawan, Anil
    Dillon, John
    Dyson, Jessica
    Ferguson, James
    Foster, Graham
    Gardner, Richard
    Gilmore, Sir Ian
    Hardman, Lesley
    Hudson, Mark
    Kelly, Deirdre
    Langford, Andrew
    Liversedge, Stephen
    Moriarty, Kieran
    Newsome, Philip
    O'Grady, John
    Pryke, Rachel
    Rolfe, Liz
    Rutter, Harry
    Ryder, Stephen
    Samyn, Marianne
    Sheron, Nick
    Taylor, Alison
    Thompson, Jeremy
    Verne, Julia
    Yeoman, Andrew
    LANCET, 2017, 389 (10083) : 2053 - 2080
  • [43] Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease
    To, Keii
    Okada, Kosuke
    Watahiki, Takahisa
    Suzuki, Hideo
    Tsuchiya, Kiichiro
    Tokushige, Katsutoshi
    Yamamoto, Masakazu
    Ariizumi, Shun-ichi
    Shoda, Junichi
    CANCER MEDICINE, 2023, 12 (19): : 19423 - 19437
  • [44] New insights into the coagulopathy of liver disease and liver transplantation
    M Senzolo
    P Burra
    E Cholongitas
    AK Burroughs
    World Journal of Gastroenterology, 2006, (48) : 7725 - 7736
  • [45] New insights into the coagulopathy of liver disease and liver transplantation
    Senzolo, M.
    Burra, P.
    Cholongitas, E.
    Burroughs, A. K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (48) : 7725 - 7736
  • [46] Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets
    Scioli, Maria Giovanna
    Storti, Gabriele
    D'Amico, Federico
    Rodriguez Guzman, Roger
    Centofanti, Federica
    Doldo, Elena
    Cespedes Miranda, Ela Maria
    Orlandi, Augusto
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 39
  • [47] Targets for new immunomodulation strategies in inflammatory bowel disease
    Monteleone, Giovanni
    Caruso, Roberta
    Pallone, Francesco
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 11 - 14
  • [48] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [49] Chronic Liver Disease and Promising Therapeutic Strategy: A Concise Review
    Yu, Han
    Wang, Zhijun
    Zhao, Gang
    PHARMACOGNOSY MAGAZINE, 2024, 20 (04) : 1031 - 1047
  • [50] The lipidome in nonalcoholic fatty liver disease: actionable targets
    Pirola, Carlos J.
    Sookoian, Silvia
    JOURNAL OF LIPID RESEARCH, 2021, 62
12345